Product Information
DEXAMETHASONE 4 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1928 per EA under NDC 72888024001. Its NADAC has been published 32 times since Feb 25, 2026.
FDA first approved this application on Sep 17, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888024001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONEApproval Type
Generic (ANDA)
FDA Application
ANDA218372FDA Approved
9/17/2024
TE Code
AB
On Market Since
10/15/2025
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 4 MG TABLET has been published 32 times since Feb 25, 2026, and over the history we have for it it has declined 8.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1928 per EA |
|---|---|
| All-time high | $0.2158 (Jul 15, 2026) |
| All-time low | $0.1876 (Aug 19, 2026) |
| 52-week high | $0.2158 |
| 52-week low | $0.1876 |
| Median price | $0.1972 |
| Average price | $0.2001 |
| Largest weekly change | -7.8% (Jul 22, 2026) |
| Weeks tracked | 32 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXAMETHASONE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXAMETHASONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 4 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1928 per EA (NDC 72888024001), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 4 MG TABLET has declined 8.2%. It has been tracked across 32 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 4 MG TABLET?
Since Feb 25, 2026, the NADAC for DEXAMETHASONE 4 MG TABLET has ranged from a low of $0.1876 (Aug 19, 2026) to a high of $0.2158 (Jul 15, 2026), with a median of $0.1972 per EA.
Are there cheaper alternatives to DEXAMETHASONE 4 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DEXAMETHASONE 4 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXAMETHASONE 4 MG TABLET?
DEXAMETHASONE 4 MG TABLET (NDC 72888024001) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.